Cancer BiologybioRxivPreprint
RIG-I RNA agonist activates immunostimulatory macrophages to enhance checkpoint immunotherapy for glioblastoma
Han Xu, Sungwoon Lee, Felipe Saceanu Leser…·Jean‐Léon Thomas
The paper shows that activating RIG-I in macrophages enhances immunotherapy for glioblastoma by repolarizing tumor-associated macrophages and boosting anti-tumor immune responses.
1 citation